Month: November 2021

Junshi Biosciences Announces Approval of Supplemental New Drug Application by NMPA for Toripalimab in Combination with Cisplatin and Gemcitabine as First-Line Treatment for Patients with Locally Recurrent or Metastatic Nasopharyngeal Carcinoma

4th approved indication for toripalimab SHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) announced today that the National Medical Products Administration (NMPA) of China has approved its supplemental New Drug Application (sNDA) for toripalimab in combination with cisplatin and

Read more

South Africa Teenage Pregnancy Spikes During Pandemic

South Africa’s teenage pregnancy rate has jumped 60% amid the COVID-19 pandemic, an increase affecting the education of many young women and their hopes to escape the cycle of poverty.When schoolgirls in South Africa become pregnant, only one-third ret…

Read more

Recent News